Österroos A

Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma.

Nikkarinen A, Almlöf J, Österroos A, ..., Baliakas P, Glimelius I

Leukemia 40 (3) 681-684 [2026-03-00; online 2026-02-04]

Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative]

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.

Eriksson A, Engvall M, Mathot L, ..., Ladenvall C, Baliakas P

Clin. Cancer Res. 29 (15) 2826-2834 [2023-08-01; online 2023-04-07]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative] NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Prediction model for drug response of acute myeloid leukemia patients.

Trac QT, Pawitan Y, Mou T, ..., Kallioniemi O, Vu TN

NPJ Precis Oncol 7 (1) 32 [2023-03-24; online 2023-03-24]

Bioinformatics Support for Computational Resources [Service]

Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia.

Österroos A, Björklund M, Eriksson A, ..., Grönberg H, Lehmann S

Blood Cancer J 10 (6) 67 [2020-06-11; online 2020-06-11]

Bioinformatics Support for Computational Resources [Service]